Ramesh K. Goyal
6 Papers
Ramesh K. Goyal is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 4 publications.
Chat about Author
Papers
Complex Mutation Pattern of Omicron BA.2: Evading Antibodies without Losing Receptor Interactions
Saathvik R. Kannan,Austin N. Spratt,Kalicharan Sharma,Ramesh K. Goyal,Anders Sönnerborg,Subbu Apparsundaram,Christian L. Lorson,Siddappa N. Byrareddy,Kamal S. Singh +8 more
TL;DR: Analysis of available sequences, structures of Spike/receptor and Spike/antibody complexes, and molecular dynamics simulations suggested that BA.2 evolved with novel mutations to maintain receptor binding similar to WT, evade the antibody binding greater than BA.1, and acquire mutation of the Delta variant that may be associated with the high infectivity.
Experiences and challenges of African traditional medicine: lessons from COVID-19 pandemic
Polydor Ngoy Mutombo,Ossy M.J. Kasilo,Peter James,Jon Wardle,O. Kunle,David R. Katerere,C. Wambebe,Motlalepula G. Matsabisa,Mohammed Rahmatullah,Jean-Baptiste Nikiema,Immaculee Mukankubito,R. Sheridan,Rokia Sanogo,Veeranoot Nissapatorn,Chaisith Sivakorn,Satyajit Tripathy,Ramesh K. Goyal,Mahaveer Dhobi +17 more
TL;DR: African scientists, with some support from their governments, and guidance from WHO and other bodies, are addressing this evidence gap, developing and testing herbal medicines based on ATMs to manage mild-to-moderate cases of COVID-19.
11
Recent advances in synthetic strategies and SAR of thiazolidin-4-one containing molecules in cancer therapeutics
Archana Sharma,Diksha Sharma,N. Saini,Sunil Sharma,Vijay Kumar Thakur,Ramesh K. Goyal,Prabodh Chander Sharma +6 more
TL;DR: In this paper , the authors highlight the various synthetic, green, and nanomaterial-based synthesis routes of thiazolidin-4-ones as well as their role in anticancer activity by inhibition of various enzymes and cell lines.
Green synthesis of silver nanoparticles using Ocimum sanctum Linn. and its antibacterial activity against multidrug resistant Acinetobacter baumannii
Deepan Gautam,Karma G Dolma,Bidita Khandelwal,Madhu Gupta,Meghna Singh,Tooba Mahboob,Anil Kumar Teotia,Prasad Thota,Jaydeep Bhattacharya,Ramesh K. Goyal,Sonia M.R. Oliveira,Maria de Lourdes Pereira,Christophe Wiart,Polrat Wilairatana,Komgrit Eawsakul,Mohammed Rahmatullah,S. Saravanabhavan,Veeranoot Nissapatorn +17 more
TL;DR: The cytotoxicity test using the MTT assay protocol showed that prepared nanoparticles of O. sanctum are less toxic against human cell A549, and opens up a ray of hope to explore the further research in this area and to improve the antimicrobial activities against multidrug resistant bacteria.
10
Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate
TL;DR: In this paper , the authors proposed the possible role of Solanum nigrum in managing the symptoms of COVID-19 and its post-COVID complications based on in silico docking and pharmacological studies.
4